Search

Search Constraints

You searched for: Author/Creator Chen, Mei-Jyh

Search Results

1. 14 day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: a multicentre, non-inferiority, randomized trial. (29th May 2018)

2. Accuracy of faecal occult blood test and Helicobacter pylori stool antigen test for detection of upper gastrointestinal lesions. Issue 10 (30th October 2013)

4. Comparison of the effect of clarithromycin triple therapy with or without N-acetylcysteine in the eradication of Helicobacter pylori: a randomized controlled trial. (July 2020)

5. Comparison of the effect of clarithromycin triple therapy with or without N-acetylcysteine in the eradication of Helicobacter pylori: a randomized controlled trial. (July 2020)

6. Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. Issue 10058 (12th November 2016)

7. Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria. Issue 10 (18th November 2014)

8. Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover design. Issue 5 (28th April 2010)

9. Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus. Issue 12 (1st October 2020)

10. Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial. (March 2023)